APTEKA +, ZAO, Udmurt Republic

Economic indicators

Net loss (RA) of APTEKA +, ZAO made up 8.30 million RUB over 2023 compared to net profit of 1.16 million RUB over 2022, the company informed.

Revenue decreased in the accounting period by 45.18% to 26.41 million RUB from 48.18 million RUB in 2022; cost of goods sold decreased by 41.93% to 24.77 million RUB from 42.66 million RUB; sales loss made up 14.13 million RUB compared to sales profit of 113.00 thousand RUB.

Net profit (RAS) of APTEKA +, ZAO grew over 2022 by 0.52% to 1.16 million RUB from 1.16 million RUB over 2021, the company informed.

Revenue decreased in the accounting period by 6.24% to 48.18 million RUB from 51.38 million RUB in 2021; cost of goods sold decreased by 5.77% to 42.66 million RUB from 45.28 million RUB; sales profit made up 113.00 thousand RUB compared to sales loss of 5.81 million RUB.

Net profit (RAS) of APTEKA +, ZAO made up 1.16 million RUB over 2021 compared to net loss of 559.00 thousand RUB over 2020, the company informed.

Revenue decreased in the accounting period by 23.66% to 51.38 million RUB from 67.31 million RUB in 2020; cost of goods sold decreased by 25.68% to 45.28 million RUB from 60.92 million RUB; sales loss grew by 20.71% to 5.81 million RUB from 4.81 million RUB.

Net loss (RAS) of APTEKA +, ZAO dropped over 2020 10.54 times to 559.00 thousand RUB from 5.89 million RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period by 4.91% to 67.31 million RUB from 64.15 million RUB over 2019; cost of goods sold grew by 4.75% to 60.92 million RUB from 58.15 million RUB; sales loss decreased 2.34 times to 4.81 million RUB from 11.26 million RUB.

Net loss (RA) of APTEKA +, ZAO made up 5.89 million RUB over 2019 compared to net profit of 968.00 thousand RUB over 2018, the company informed.

Revenue decreased in the accounting period by 20.91% to 64.15 million RUB from 81.12 million RUB in 2018; cost of goods sold decreased by 14.44% to 58.15 million RUB from 67.97 million RUB; sales loss made up 11.26 million RUB compared to sales profit of 1.10 million RUB.

Net profit (RAS) of APTEKA +, ZAO dropped in 2018 5.82 times to 968.00 thousand RUB from 5.64 million RUB over the same period in 2017, the company informed.

Revenue decreased in the accounting period by 15.85% to 81.12 million RUB from 96.40 million RUB in 2017; cost of goods sold decreased by 8.83% to 67.97 million RUB from 74.56 million RUB; sales profit fell 5.41 times to 1.10 million RUB from 5.98 million RUB.

Net profit (RAS) of APTEKA +, ZAO grew over 2017 32.21 times to 5.64 million RUB from 175.00 thousand RUB over 2016, the company informed.

Revenue remained in the accounting period at the same level and made up 96.40 million RUB compared to 96.23 million RUB 96.23 million RUB; cost of goods sold decreased by 5.41% to 74.56 million RUB from 78.82 million RUB; sales profit went up 10.71 times to 5.98 million RUB from 558.00 thousand RUB.

Net profit (RAS) of APTEKA +, ZAO dropped in 2016 by 41.47% to 175.00 thousand RUB from 299.00 thousand RUB over the same period in 2015, the company informed.

Revenue decreased in the accounting period by 22.47% to 96.23 million RUB from 124.12 million RUB in 2015; cost of goods sold decreased by 16.56% to 78.82 million RUB from 94.46 million RUB; sales profit fell by 17.58% to 558.00 thousand RUB from 677.00 thousand RUB.

Net profit (RAS) of APTEKA +, ZAO dropped in 2013 4.74 times to 351.00 thousand RUB from 1.67 million RUB over the same period in 2012, the company informed.

Revenue increased in the accounting period by 9.43% to 168.01 million RUB from 153.53 million RUB over 2012; cost of goods sold grew by 11.62% to 151.21 million RUB from 135.46 million RUB; sales profit fell 2.85 times to 692.00 thousand RUB from 1.97 million RUB.

Companies in the region

• TOREL
• AZIMUT
• TD NA RODNIKOVOY
• UZDEU AVTO-IZHEVSK
• TSENTR OBUCHENIYA I RAZVITIYA DELOVYKH NAVYKOV